Cancer diagnostics News and Research

RSS

Study examines health behaviors in children post-cancer diagnosis

In a Psycho-Oncology study of childhood cancer survivors, several health behaviors fell short of expectations for exercise and diet during early survivorship, and they remained sub-optimal upon reaching five years post-diagnosis.

7 Nov 2018

Low risk thyroid cancer patients can be treated with smaller amount of radiation, suggests study

Thyroid cancer patients whose disease is at low risk of returning can be treated safely with a smaller amount of radiation following surgery, according to results from the world's longest running trial to investigate this.

5 Nov 2018

Researchers develop diagnostic test to determine risk of developing malignant breast cancer

Currently, with a pre-malignant breast cancer diagnosis from a biopsy, there are three options: observation, chemoprevention or surgery, all of which require a patient to make decisions while operating from a place of fear and unknown outcomes.

31 Oct 2018

New ddPCR technology helps detect, quantify TERT promoter mutations linked to many cancer types

A recent study published online in the Journal of Molecular Diagnostics demonstrated that Droplet Digital PCR technology can be used to detect mutations in a region of our DNA that is linked to many cancer types, paving the way for the development of new cancer diagnostics and therapies.

31 Oct 2018

Study highlights accuracy of DecisionDx-Melanoma prognostic test in patients with Stage II-IIIA melanoma

Castle Biosciences, Inc., the skin cancer diagnostics company providing molecular diagnostics to improve cancer management decisions, today announced the presentation of data highlighting how the accuracy of the DecisionDx-Melanoma gene expression profile (GEP) test in patients with Stage II and IIIA melanoma can improve adjuvant clinical trial design at the 2018 Society for Melanoma Research International Congress held in Manchester, England from October 24-27.

30 Oct 2018

New ultrasound technique shows great promise in detecting breast cancer

A new ultrasound technique can help distinguish benign breast tumors from malignant ones. The technology was developed with support from the Swiss National Science Foundation.

30 Oct 2018

Quantum dot-based FISH method enhances cell imaging

A team of researchers from the University of Illinois at Urbana-Champaign and Mayo Clinic have engineered a new type of molecular probe that can measure and count RNA in cells and tissue without organic dyes.

30 Oct 2018

Head and neck cancer survivors more likely to commit suicide

Despite improved survival rates among cancer patients, the risk of death by suicide remains high, especially among those treated for head and neck cancers.

25 Oct 2018

Novel blood test shows promise for monitoring HPV-linked head and neck cancer after treatment

A new blood test developed by University of North Carolina Lineberger Comprehensive Cancer Center researchers shows promise for tracking HPV-linked head and neck cancer patients to ensure they remain cancer-free after treatment.

23 Oct 2018

New medical navigation system receives international innovation award

The team behind a new medical navigation system which makes it easier to take biopsy samples from the lungs recently received an international innovation award during Innovation Expo 2018 in Rotterdam.

23 Oct 2018

New statistical method estimates long- and short-term risk of recurrence of breast cancer in US women

A statistical method could fill the gaps in the U.S. cancer registry data to estimate the short- and long-term risk of recurrence of hormone receptor (HR)-positive and HR-negative breast cancers.

19 Oct 2018

Study: Sarcoma patients poorly informed about risk of interactions with anti-cancer drugs

Sarcoma patients show great openness to the use of complementary alternative medicines (CAMs) for supportive care, but they are poorly informed about safety issues and risk of interactions with anti-cancer drugs, a study to be presented at ESMO 2018 reported.

10 Oct 2018

Study finds suboptimal antithrombotic care in AFib patients with cancer history

Atrial fibrillation patients with a history of cancer are less likely to see a cardiologist or fill anticoagulant prescriptions compared with AFib patients who never had cancer, according to a study in the Journal of the American College of Cardiology.

8 Oct 2018

CPEN honors Penn Medicine's OncoLink with 2018 Excellence in Patient Education Award

The Cancer Patient Education Network (CPEN) honored the Patient Education Team from Penn Medicine's OncoLink with the 2018 Excellence in Patient Education Award.

8 Oct 2018

Presence of high-risk HPV in cervical cancer diagnosis linked to improved prognosis

The presence of the human high-risk papillomavirus in the diagnosis of invasive cervical cancer is linked to a greatly improved prognosis compared with if high-risk HPV cannot be identified in the tumor, researchers at Karolinska Institutet in Sweden report in the scientific journal PLOS Medicine.

3 Oct 2018

Early PSA testing in black men could help predict future development of prostate cancer

Prostate cancer is the second most common cancer in American men. But black men bear a disproportionate burden of its effects. It's more common - and more than twice as deadly - among black men compared to their white counterparts.

3 Oct 2018

Researchers caution that expediting HLH treatment may miss underlying cancers

Physicians who specialize in a devastating and aggressive immune disorder called hemophagocytic lymphohistiocytosis report in a new study that extra care should be taken to ensure an HLH diagnosis doesn't obscure possible underlying cancers.

1 Oct 2018

Australian scientists resolve a key question in ovarian cancer care

Australian scientists have revealed a better way to identify which patients should respond to powerful ovarian cancer drugs called PARP inhibitors (PARPi), resolving an important question in ovarian cancer care about why some patients respond to these drugs, while others do not.

28 Sep 2018

Study: Second opinion can potentially change the diagnosis of breast cancer patients

It's early morning and a team of more than 20 professionals cram around a long table in a dark room, peering at slide after slide of black-and-white mammogram images crossing the screen.

26 Sep 2018

Study: Over 80% of people who carry identifiable genetic risk for cancer don't know it

Genomic screening of more than 50,000 people shows that more than 80% of those who carry an identifiable genetic risk for breast, ovarian, prostate, and pancreatic cancer don't know it despite frequent interaction with the healthcare system.

24 Sep 2018

Cancer diagnostics News and Research

Study examines health behaviors in children post-cancer diagnosis

Low risk thyroid cancer patients can be treated with smaller amount of radiation, suggests study

Researchers develop diagnostic test to determine risk of developing malignant breast cancer

New ddPCR technology helps detect, quantify TERT promoter mutations linked to many cancer types

Study highlights accuracy of DecisionDx-Melanoma prognostic test in patients with Stage II-IIIA melanoma

New ultrasound technique shows great promise in detecting breast cancer

Quantum dot-based FISH method enhances cell imaging

Head and neck cancer survivors more likely to commit suicide

Novel blood test shows promise for monitoring HPV-linked head and neck cancer after treatment

New medical navigation system receives international innovation award

New statistical method estimates long- and short-term risk of recurrence of breast cancer in US women

Study: Sarcoma patients poorly informed about risk of interactions with anti-cancer drugs

Study finds suboptimal antithrombotic care in AFib patients with cancer history

CPEN honors Penn Medicine's OncoLink with 2018 Excellence in Patient Education Award

Presence of high-risk HPV in cervical cancer diagnosis linked to improved prognosis

Early PSA testing in black men could help predict future development of prostate cancer

Researchers caution that expediting HLH treatment may miss underlying cancers

Australian scientists resolve a key question in ovarian cancer care

Study: Second opinion can potentially change the diagnosis of breast cancer patients

Study: Over 80% of people who carry identifiable genetic risk for cancer don't know it

eBook: Liquid biopsy in cancer research eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News